See also this year's filing and all EDGAR filings for this company.
PDF Report 0001845337_2023_Day_One_Biopharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 10, '100050 - Statement - Consolidated Statements of Comprehensive Loss': 2}} |
Graph
Absolute values for 0001845337, Day One Biopharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 347,874,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 20,000 |
| 3 | remainder_Assets | 1,168,000 |
| 4 | LiabilitiesCurrent | 16,615,000 |
| 5 | LiabilitiesNoncurrent | 408,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 61,291,000 |
| 9 | ResearchAndDevelopmentExpense | 85,618,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,728,000 |
| 13 | remainder_ComprehensiveNetIncome | -71,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 349,062,000 |
| 1 | Liabilities | 17,023,000 |
| 2 | Expenses | 146,909,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 332,039,000 |
| 5 | NetIncome | -142,181,000 |
| 6 | ComprehensiveNetIncome | -142,216,500 |
| 7 | BaseVar | 258,896,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.18 |
| 9 | EconomicCapitalRatio | 3.81 |
Edgar->Model Mapping
Feature Distribution
